In a murine model, local rhBMP-2 application was shown to enter the bloodstream, leading to the development of hepatic tumors due to the proliferation of myelodysplastic syndrome (MDS) cells and increased secretion of IL-6 [38]. The gene discussed is IL6; the disease is myelodysplastic syndrome.